223 related articles for article (PubMed ID: 33303711)
1. Immunosuppressive Drug Measurement by Liquid Chromatography Coupled to Tandem Mass Spectrometry: Interlaboratory Comparison in the Korean Clinical Laboratories.
Kim HK; Park HD; Lee SG; Chae H; Song SH; Lee YW; Yun YM; Ahn S; Kim S; Lee SM; Lee SY; Chun S;
Ann Lab Med; 2021 May; 41(3):268-276. PubMed ID: 33303711
[TBL] [Abstract][Full Text] [Related]
2. Salting Out-Assisted Liquid-Liquid Extraction for Liquid Chromatography-Tandem Mass Spectrometry Measurement of Tacrolimus, Sirolimus, Everolimus, and Cyclosporine a in Whole Blood.
Kvamsøe MM; Hansen KR; Skadberg Ø; Vethe NT; Brede C
Ther Drug Monit; 2020 Oct; 42(5):695-701. PubMed ID: 32701594
[TBL] [Abstract][Full Text] [Related]
3. Long-Term Performance of Laboratory-Developed Liquid Chromatography-Tandem Mass Spectrometry Tests and a Food and Drug Administration-Approved Immunoassay for the Therapeutic Drug Monitoring of Everolimus.
Schniedewind B; Meyer EJ; Christians U
Ther Drug Monit; 2020 Jun; 42(3):421-426. PubMed ID: 32427781
[TBL] [Abstract][Full Text] [Related]
4. Robust, high-throughput LC-MS/MS method for therapeutic drug monitoring of cyclosporine, tacrolimus, everolimus, and sirolimus in whole blood.
Koster RA; Dijkers EC; Uges DR
Ther Drug Monit; 2009 Feb; 31(1):116-25. PubMed ID: 19065123
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the first immunosuppressive drug assay available on a fully automated LC-MS/MS-based clinical analyzer suggests a new era in laboratory medicine.
Hörber S; Peter A; Lehmann R; Hoene M
Clin Chem Lab Med; 2021 Apr; 59(5):913-920. PubMed ID: 33068377
[TBL] [Abstract][Full Text] [Related]
6. An isotope dilution LC-MS/MS based candidate reference method for the quantification of cyclosporine A, tacrolimus, sirolimus and everolimus in human whole blood.
Taibon J; van Rooij M; Schmid R; Singh N; Albrecht E; Anne Wright J; Geletneky C; Schuster C; Mörlein S; Vogeser M; Seger C; Pongratz S; Kobold U
Clin Biochem; 2020 Aug; 82():73-84. PubMed ID: 31770523
[TBL] [Abstract][Full Text] [Related]
7. Multiplex Immunosuppressant (ISD) Method for the Measurement of Cyclosporine A, Tacrolimus, Sirolimus/Rapamycin, and Everolimus in Whole Blood Using MassTrak™ Kit.
Zhang A; Conklin SE
Methods Mol Biol; 2024; 2737():307-318. PubMed ID: 38036832
[TBL] [Abstract][Full Text] [Related]
8. Interlaboratory comparison study of immunosuppressant analysis using a fully automated LC-MS/MS system.
Zahr N; Duce H; Duffy J; Webster C; Rentsch KM
Clin Chem Lab Med; 2022 Oct; 60(11):1753-1762. PubMed ID: 36044751
[TBL] [Abstract][Full Text] [Related]
9. Quantitative determination of four immunosuppressants by high resolution mass spectrometry (HRMS).
Bruns K; Mönnikes R; Lackner KJ
Clin Chem Lab Med; 2016 Jul; 54(7):1193-200. PubMed ID: 26641969
[TBL] [Abstract][Full Text] [Related]
10. Fast LC-MS/MS analysis of tacrolimus, sirolimus, everolimus and cyclosporin A in dried blood spots and the influence of the hematocrit and immunosuppressant concentration on recovery.
Koster RA; Alffenaar JW; Greijdanus B; Uges DR
Talanta; 2013 Oct; 115():47-54. PubMed ID: 24054560
[TBL] [Abstract][Full Text] [Related]
11. A direct method for the measurement of everolimus and sirolimus in whole blood by LC-MS/MS using an isotopic everolimus internal standard.
Morgan PE; Brown NW; Tredger JM
Ther Drug Monit; 2014 Jun; 36(3):358-65. PubMed ID: 24305629
[TBL] [Abstract][Full Text] [Related]
12. Two rapid ultra performance liquid chromatography/tandem mass spectrometry (UPLC/MS/MS) methods with common sample pretreatment for therapeutic drug monitoring of immunosuppressants compared to immunoassay.
Tszyrsznic W; Borowiec A; Pawlowska E; Jazwiec R; Zochowska D; Bartlomiejczyk I; Zegarska J; Paczek L; Dadlez M
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Jun; 928():9-15. PubMed ID: 23584041
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic drug monitoring of immunosuppressants by liquid chromatography-mass spectrometry.
McShane AJ; Bunch DR; Wang S
Clin Chim Acta; 2016 Feb; 454():1-5. PubMed ID: 26721314
[TBL] [Abstract][Full Text] [Related]
14. Multicenter evaluation of the thermo scientific prelude for measurement of immunosuppressant drugs using sample preparation liquid chromatography-tandem mass spectrometry.
Peake RW; Hartigan CR; Esposito CL; Kellogg MD; Gabler J; Wang S; Breaud A; Di Bussolo J; Moskowitz J; Clarke W
Ther Drug Monit; 2015 Apr; 37(2):161-71. PubMed ID: 25072947
[TBL] [Abstract][Full Text] [Related]
15. High-throughput LC-MS/MS method for monitoring sirolimus and everolimus in the routine clinical laboratory.
Ivanova M; Artusi C; Polo G; Zaninotto M; Plebani M
Clin Chem Lab Med; 2011 Jul; 49(7):1151-8. PubMed ID: 21574883
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic Drug Monitoring of Everolimus: Comparability of Concentrations Determined by 2 Immunoassays and a Liquid Chromatography Tandem Mass Spectrometry Method.
Shipkova M; Rapp S; Rigo-Bonnin R; Wieland E; Peter A
Ther Drug Monit; 2017 Apr; 39(2):102-108. PubMed ID: 28125504
[TBL] [Abstract][Full Text] [Related]
17. Long-term cross-validation of everolimus therapeutic drug monitoring assays: the Zortracker study.
Schniedewind B; Niederlechner S; Galinkin JL; Johnson-Davis KL; Christians U; Meyer EJ
Ther Drug Monit; 2015 Jun; 37(3):296-303. PubMed ID: 25970506
[TBL] [Abstract][Full Text] [Related]
18. Liquid chromatography-tandem mass spectrometry outperforms fluorescence polarization immunoassay in monitoring everolimus therapy in renal transplantation.
Moes DJ; Press RR; de Fijter JW; Guchelaar HJ; den Hartigh J
Ther Drug Monit; 2010 Aug; 32(4):413-9. PubMed ID: 20535052
[TBL] [Abstract][Full Text] [Related]
19. Comparison of a stable isotope-labeled and an analog internal standard for the quantification of everolimus by a liquid chromatography-tandem mass spectrometry method.
Heideloff C; Payto D; Wang S
Ther Drug Monit; 2013 Apr; 35(2):246-50. PubMed ID: 23503452
[TBL] [Abstract][Full Text] [Related]
20. Analytical performance of a new liquid chromatography/tandem mass spectrometric method for determination of everolimus concentrations in whole blood.
McMillin GA; Johnson-Davis K; Dasgupta A
Ther Drug Monit; 2012 Apr; 34(2):222-6. PubMed ID: 22322402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
